Talphera (TLPH) Total Current Liabilities (2010 - 2026)
Talphera (TLPH) recorded quarterly Total Current Liabilities of $4.0 million in Q1 2026, up 5.67% quarter-over-quarter from $3.8 million in Q4 2025, and up 102.36% on a YoY basis from $2.0 million in Q1 2025.
Talphera (TLPH) Total Current Liabilities (2010 - 2026) Analysis & Trends
Talphera's Total Current Liabilities history runs 17 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 102.36% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $4.0 million (up 102.36% YoY), while the FY2025 annual figure was $3.8 million, up 43.9% from the prior year.
- Total Current Liabilities was $4.0 million for Q1 2026 at Talphera, up from $3.8 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $17.7 million in Q2 2022 to a low of $2.0 million in Q1 2025.
- Historically, Total Current Liabilities has averaged $6.7 million across 5 years, with a median of $3.8 million in 2025.
- The sharpest annual moves came in 2023 and 2026: Total Current Liabilities plunged 77.16% in 2023, then soared 102.36% in 2026.
- A 5-year view of Total Current Liabilities shows it stood at $13.8 million in 2022, then slumped by 67.23% to $4.5 million in 2023, then plunged by 41.33% to $2.6 million in 2024, then surged by 43.9% to $3.8 million in 2025, then advanced by 5.67% to $4.0 million in 2026.
- The last three Total Current Liabilities figures came in at $4.0 million (Q1 2026), $3.8 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 618.78 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 333.17 Mn |
| 10 | Talphera | 56.42 Mn | 56.42 Mn | - | 4.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.03 Mn |
| Dec 31, 2025 | 3.81 Mn |
| Sep 30, 2025 | 3.21 Mn |
| Jun 30, 2025 | 2.63 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 2.65 Mn |
| Sep 30, 2024 | 2.76 Mn |
| Jun 30, 2024 | 3.27 Mn |
| Mar 31, 2024 | 3.34 Mn |
| Dec 31, 2023 | 4.51 Mn |
| Sep 30, 2023 | 3.57 Mn |
| Jun 30, 2023 | 4.22 Mn |
| Mar 31, 2023 | 9.46 Mn |
| Dec 31, 2022 | 13.77 Mn |
| Sep 30, 2022 | 15.65 Mn |
| Jun 30, 2022 | 17.69 Mn |
| Mar 31, 2022 | 17.03 Mn |
| Dec 31, 2021 | 18.51 Mn |
| Sep 30, 2021 | 17.07 Mn |
| Jun 30, 2021 | 15.19 Mn |